Delivery Order SPE2DR25D9628-SPE2DR26FBTNF

The Defense Logistics Agency issued a delivery order valued at $10,844.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for TICOVAC 2.4MCG/0.5 10S. The delivery order was awarded on February 3, 2026, with an ultimate completion date of February 12, 2026, under a firm fixed-price contract structure with no set-aside designation. DMS Pharmaceutical Group was selected based on its competitive capability and established performance as a critical supplier within the federal pharmaceutical supply chain serving Department of Defense healthcare operations.

This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical products and medical consumables to military healthcare facilities worldwide. The underlying IDC, valued at $499,999,999 and effective through December 31, 2036, establishes DMS Pharmaceutical Group as a regional prime vendor contractor capable of fulfilling diverse and specialized pharmaceutical requirements for the Department of Defense. The company's woman-owned small business status and extensive product portfolio spanning branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals position it as a key contributor to DoD's global medical supply operations.